Sarah Wythe

Sarah Wythe is a seasoned professional in the field of research with extensive experience in cell and gene therapy and tumour immunology. Currently serving as the Vice President of Research at Vianautis since December 2023, Sarah previously held the position of Research Director at Evox Therapeutics Ltd from January 2021 to December 2023. Prior roles include Group Lead at GammaDelta Therapeutics (2017-2021), Senior Scientist at Oxford Biomedica (2015-2017), and Postdoctoral Research Associate at the University of Oxford (2012-2015). Sarah began a distinguished academic career as a Post-doctoral Research Fellow at Barts and the London School of Medicine and Dentistry (2008-2011). Education includes a PhD in Cellular Immunology from Imperial College London (2005-2008) and a Master of Science in Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine (2001-2002).